Skyla is owned by Bayer Hlthcare.
Skyla contains Levonorgestrel.
Skyla has a total of 5 drug patents out of which 0 drug patents have expired.
Skyla was authorised for market use on 09 January, 2013.
Skyla is available in intrauterine device;intrauterine dosage forms.
Skyla can be used as a method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system, a method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus.
The generics of Skyla are possible to be released after 01 April, 2031.
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7252839 | BAYER HLTHCARE | Delivery system and a manufacturing process of a delivery system |
Nov, 2023
(9 months from now) | |
US9615965 | BAYER HLTHCARE | Inserter |
Sep, 2029
(6 years from now) | |
US10561524 | BAYER HLTHCARE | Inserter |
Sep, 2029
(6 years from now) | |
US10987244 | BAYER HLTHCARE | Inserter |
Apr, 2031
(8 years from now) | |
US9668912 | BAYER HLTHCARE | Inserter |
Apr, 2031
(8 years from now) |
Drugs and Companies using LEVONORGESTREL ingredient
Market Authorisation Date: 09 January, 2013
Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system; A method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus
Dosage: INTRAUTERINE DEVICE;INTRAUTERINE
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic